Delivery Order SPE2DB20D3304-SPE2DB24FW6T5

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,544.69 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $17,821.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Defense Logistics Agency awarded a $9,124.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,562,696,707 units of Eliquis 5 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This $14,639.33 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Eliquis 5 mg tablets. The contract has an ultimate completion date of December 12, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,543.96 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract has no...
The U.S. Defense Logistics Agency (DLA) awarded a $39,812.35 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Eliquis 5 mg tablet 60 count. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,948.68 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Eliquis 5 mg tablets over the period ending on September 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded a $4,909.62 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is to supply 4,565,531,240 units of the pharmaceutical product Eliquis 5 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities from...
The federal government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract, valued at $2,505.25, has an ultimate completion date of November 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The $5,377.11 contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has an ultimate completion date of October 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW6T5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $6,418.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by July 17, 2024.

Generated 10/15/24, 9:34 PM